Arsenic trioxide as a novel anti-glioma drug: a review.

Arsenic trioxide as a novel anti-glioma drug: a review.
Cell Mol Biol Lett. 2020;25:44
Authors: Fang Y, Zhang Z
Abstract
Arsenic trioxide has shown a strong anti-tumor effect with little toxicity when used in the treatment of acute promyelocytic leukemia (APL). An effect on glioma has also been shown. Its mechanisms include regulation of apoptosis and autophagy; promotion of the intracellular production of reactive oxygen species, causing oxidative damage; and inhibition of tumor stem cells. However, glioma cells and tissues from other sources show different responses to arsenic trioxide. Researchers are working to enhance its efficacy in anti-glioma treatments and reducing any adverse reactions. Here, we review recent research on the efficacy and mechanisms of action of arsenic trioxide in the treatment of gliomas to provide guidance for future studies.
PMID: 32983240 [PubMed - in process]

Source: Cellular and Molecular Biology Letters - September 30, 2020 Category: Biochemistry Authors: Fang Y, Zhang Z Tags: Cell Mol Biol Lett Source Type: research